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TRPV1 plays a key role in nociception, as it is
activated by heat, low pH, and ligands such as
capsaicin, leading to a burning pain sensation.
We describe the structure of the cytosolic
ankyrin repeat domain (ARD) of TRPV1 and
identify a multiligand-binding site important in
regulating channel sensitivity within the TRPV1-
ARD. The structure reveals a binding site that
accommodates triphosphate nucleotides such
as ATP, and biochemical studies demonstrate
that calmodulin binds the same site. Electro-
physiology experiments show that either ATP
or PIP2 prevent desensitization to repeated
applications of capsaicin, i.e., tachyphylaxis,
while calmodulin plays an opposing role and is
necessary for tachyphylaxis. Mutations in the
TRPV1-ARD binding site eliminate tachyphy-
laxis. We present a model for the calcium-
dependent regulation of TRPV1 via competitive
interactions of ATPandcalmodulin at theTRPV1-
ARD-binding site and discuss its relationship to
the C-terminal region previously implicated in
interactions with PIP2 and calmodulin.
INTRODUCTION
The six mammalian TRP channels of the vanilloid subfam-
ily (TRPV) are important in sensory and pain perception
and in calcium homeostasis. TRPV1, a nonselective cation
channel expressed in peripheral nociceptor sensory neu-
rons, is responsible for sensing noxious heat (>42C)
and transducing inflammatory pain signals (reviewed in
Caterina and Julius, 2001 and Tominaga and Tominaga,
2005). At a molecular level, TRPV1 is activated by noxious
heat, low extracellular pH (Caterina et al., 1997; Tominaga
et al., 1998), and several ligands, including vanilloids such
as capsaicin and resiniferatoxin (Caterina et al., 1997).TRPV1 undergoes two types of desensitization upon
activation by capsaicin or protons: acute (short-term)
desensitization and tachyphylaxis or loss of sensitivity to
repeated stimulations (Koplas et al., 1997). Physiologi-
cally, TRPV1 desensitization can lead to adaptation of
peripheral neurons to pain perception. The regulatory lipid
phosphatidylinositol-4,5-bisphosphate (PIP2) is a putative
intracellular modulator of TRPV1, although there is some
debate as to whether it sensitizes or desensitizes the
channel. Mutations in a C-terminal cytosolic region of
TRPV1 indicate an inhibitory role for PIP2 (Prescott and
Julius, 2003). However, others have found that PIP2 sensi-
tizes TRPV1 and that depletion leads to desensitization
(Liu et al., 2005; Stein et al., 2006). Intracellular ATP can
also sensitize TRPV1, although there is controversy about
whether it is through a direct interaction (Kwak et al., 2000)
or indirectly through PIP2 synthesis (Liu et al., 2005).
An increase in intracellular calcium concentration
causes TRPV1 desensitization, and calmodulin (CaM),
a ubiquitous calcium-sensor, may play a role in mediating
this effect (Numazaki et al., 2003; Rosenbaumet al., 2004).
CaM interacts in vitro with isolated peptides from the
TRPV1 N-terminal region in a Ca2+-dependent manner
(Rosenbaum et al., 2004), and also binds to the TRPV1
C-terminal region in a Ca2+-independent manner (Numa-
zaki et al., 2003).
TRPV proteins have large N- and C-terminal cytosolic
domains and six putative transmembrane segments
similar to those of Shaker potassium channels and, by
analogy, probably assemble as tetramers. The N-terminal
region contains six ankyrin repeats (Jin et al., 2006;
McCleverty et al., 2006) which are essential for channel
function (Hellwig et al., 2005; Jung et al., 2002). Ankyrin
repeats are 33-residue sequence motifs often involved in
protein-protein interactions. They are present in many
proteins with functions that include signaling, cytoskele-
ton integrity, transcription, and cellular localization (Mosavi
et al., 2004; Sedgwick and Smerdon, 1999). Recently, we
and others have determined the structure of the TRPV2
ankyrin repeat domain (ARD) (Jin et al., 2006; McCleverty
et al., 2006). A close homolog of TRPV1 (44% sequence
identity), TRPV2 is insensitive to capsaicin and activatedNeuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc. 905
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Multiligand-Binding Site in TRPV1 Ankyrin RepeatsTable 1. Data Collection and Refinement Statistics for TRPV1-ARD
Crystal Form I Crystal Form II
Data Collection Crystal 1 Se-Met Crystal 2
Space group P321 P321 R3
Cell dimensions: a, b, c (A˚) 124.6, 124.6, 62.8 124.7, 124.7, 62.8 99.5, 99.5, 106.7
Peak Inflection Remote
Wavelength 0.97907 0.97922 0.99298 1.5418 1.5418
Resolution (A˚) 3.3 (3.42-3.3) 3.4 (3.52-3.4) 3.2 (3.31-3.2) 3.2 (3.31-3.2) 2.7 (2.8-2.7)
Rsym 0.082 (0.271) 0.113 (0.550) 0.14 (0.408) 0.091 (0.605) 0.107 (0.569)
I / sI 9.8 (4.0) 10.5 (1.9) 5.8 (1.9) 9.1 (1.8) 24.9 (3.1)
Completeness (%) 99.6 (96.3) 99.8 (99.7) 96.0 (98.2) 98.8 (99.9) 100.0 (99.7)
Redundancy 8.8 7.0 2.7 4.5 4.5
Refinement
Resolution (A˚) 20-3.2 20-2.7
No. unique reflections 8450 9618
Rwork/Rfree 0.235 / 0.286 0.199 / 0.248
Molecules/a.u. 1 1
Residues in model 110-240, 247-359 111-358
No. atoms
Protein 1893 1998
Ligand (ATP) 31 31
Water — 72
B-factors
Protein 115.3 37.7
Ligand/ion 107.9 53.6
Water 44.9
RMS deviations
Bond lengths (A˚) 0.009 0.012
Bond angles () 1.24 1.72
One crystal was used per data set. Values in parentheses are for the highest resolution shell.at a higher temperature threshold of >52C (Caterina et al.,
1999). The TRPV2-ARD structure comprises six ankyrin
repeats. The isolated TRPV2-ARD ismonomeric, suggest-
ing that the ARD of TRPV proteins may be used for inter-
actions with regulatory factors rather than in promoting
tetrameric channel assembly.
Here we describe the crystal structure of the TRPV1-
ARD and the identification of a multiligand-binding site
that is important in regulating ion channel sensitivity. Our
structure and further mutagenesis demonstrate that
CaM and ATP interact at the same site. Using electrophys-
iology, we show that ATP directly prevents tachyphylaxis
to repeated applications of capsaicin, while CaM is neces-
sary for tachyphylaxis. We also provide further evidence
that PIP2 sensitizes TRPV1, suggesting ATP acts both di-
rectly by binding to the TRPV1-ARD in competition with
CaM and indirectly by regenerating depleted PIP2.906 Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc.RESULTS
Structure of the TRPV1-ARD
The TRPV1-ARD (residues 101–364) produced in E. coli
behaved as a monomer in solution at concentrations of
up to 300 mM, as determined by size exclusion chromato-
graphy and multiangle light scattering (data not shown).
We determined the structure of the TRPV1-ARD in two
crystal forms using a combination of multiwavelength
anomalous diffraction and molecular replacement (Table
1). The two structures are essentially identical, with an
overall root mean squared deviation (RMSD) of 0.76 A˚
over 241 Ca atoms, and crystal form II (higher resolution
at 2.7 A˚) is used for most analyses (Figure 1). The overall
TRPV1-ARD fold is very similar to TRPV2-ARD (Figure 1B;
RMSD=1.4 A˚ over 240Ca atoms) (Jin et al., 2006;McClev-
erty et al., 2006), comprising six ankyrin repeats, each
Neuron
Multiligand-Binding Site in TRPV1 Ankyrin RepeatsFigure 1. TRPV1-ARD Structure
(A) Ribbon diagram of TRPV1-ARD showing each ankyrin repeat in a distinct color with the bound ATP in stick representation.
(B) Superposition of TRPV1-ARD (cyan) and TRPV2-ARD (gold).
(C) Stereo diagram of residues within 4 A˚ of the ATP in crystal form II with polar interactions indicated by dashed lines. The final sA-weighted 2FoFc
map is contoured at 1.5s (yellow) and 5s (green) around the ATP.consisting of a pair of antiparallel a helices followed by
a ‘‘finger’’ loop. The concave surface formed by the inner
helices and fingers is often a site of protein-protein interac-
tions in other ankyrin repeat proteins (Mosavi et al., 2004;
Sedgwick and Smerdon, 1999). As in TRPV2, fingers 1,
2, and 3 and outer helices 5 and 6 are unusually long,
and a large counterclockwise twist observed in the stack-
ing of repeats four and five breaks the regularity of the
domain.
Despite their overall similarity, there are some notable
differences between the TRPV1- and TRPV2-ARD struc-
tures. One difference is the conformation of the long finger
3, which is disordered in crystal form I, folded over toward
finger 2 in crystal form II, and flexible in TRPV2 (Figure 1B)
(Jin et al., 2006). The TRPV1-ARD is significantly more
positively charged, with a calculated isoelectric point of
8.3, compared to 5.8 for TRPV2-ARD. This divergence in
surface shape and electrostatic properties likely reflects
differing biological functions, such as specificity and affin-
ity for distinct interacting partners.
ATP Interacts with a Specific Site on the TRPV1-ARD
A significant feature was not accounted for by protein res-
idues in the electron density maps of both TRPV1-ARD
structures. Based on the size and shape of this electron
density feature, together with the fact that 5 mM ATP
was present in the crystallization solutions, we modeled
it as an ATP molecule (Figure 1C). In crystal form I, two
ATPmolecules bridge the interface between two crystallo-
graphically relatedmolecules (see Figure S1 in the Supple-mental Data available with this article online), while in crys-
tal form II the TRPV1-ARDbinds ATP at the same site in the
absence of those crystal-packing interactions. The pres-
ence of ATP at the same site in both crystal forms suggests
that this interaction is specific, independent of crystal
lattice formation, and may be physiologically relevant.
The ATP-binding site is formed by the concave surface
of repeats 1–3, with positive residues R115 (inner helix 1)
and K155 and K160 (inner helix 2) interacting with the tri-
phosphate, while L163 (inner helix 2) and Y199 (finger 2)
sandwich the adenine base. The adenine N6 amine also
interacts with Q202 (finger 2) and E210 (inner helix 3)
(Figure 1C).
To determine whether the interaction of TRPV1-ARD
with ATP is also observed biochemically, we used ATP-
agarose to pull down purified TRPV1-ARD. The ATP-aga-
rose pulled down TRPV1-ARD but not TRPV2-ARD, and
free ATP competed the interaction (Figure 2). Three muta-
tions within the ATP-binding site—K155A and K160A,
which interact with the triphosphate moiety, and the
double mutation Y199A/Q202A, residues interacting with
the adenine base—impaired the TRPV1-ARD interaction
with ATP-agarose (Figures 2A and 2B). Furthermore, two
distal negative control mutations, R181A (outer helix 2)
and K265A (outer helix 4), both on the convex face of
TRPV1-ARD, did not impair ATP-agarose binding (Figures
2A and 2B). The mutational data therefore demonstrate
that the interaction with ATP is also observed bio-
chemically and requires residues identified in the crystal
structure.Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc. 907
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site, we tested whether other nucleotides could success-
fully compete the ATP-agarose interaction. Incubation
with purine triphosphate nucleotides (ATP and GTP;
Figure 2C) successfully competed the ATP-agarose pull-
down. ADP and the pyrimidine triphosphate nucleotides
(CTP and UTP) only partially competed the interaction at
the same concentration (5 mM), while AMP and cyclic
AMP did not prevent binding to ATP-agarose (Figure 2C).
In aggregate, these results indicate that both a purine
base and a triphosphate moiety are important for optimal
binding to TRPV1-ARD.
Competition experiments also indicated that the diva-
lent cations Mg2+ and Ca2+, which are chelated by the tri-
phosphate moiety of ATP, reduce binding of TRPV1-ARD
to ATP-agarose (Figure 2C). Although most intracellular
Figure 2. TRPV1-ARD Binds ATP
(A) Ca trace of the TRV1-ARD with ATP (yellow) and the sidechains of
the ATP-interacting residues (cyan) and distant negative control resi-
dues (magenta) shown as sticks.
(B and C) Coomassie-stained gels show (B) wild-type and mutant
TRPV1-ARDproteins loaded (top) andbound (bottom) toATP-agarose,
and (C) wild-type TRPV1-ARD protein bound to ATP-agarose in the
presence of the indicated concentration of competing compounds.908 Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc.ATP is chelated with Mg2+, the cellular concentration of
free ATP is still significant (0.3–0.7 mM; Taylor et al.,
1991), andATPmaywell be a relevant physiological ligand.
Furthermore, our observation of ATP bound to the con-
cave face of TRPV1-ARD is intriguing in light of previously
published data showing upregulation of TRPV1 activation
by intracellular ATP (Kwak et al., 2000). Kwak and col-
leagues likened residues 173–178 in the TRPV1 N termi-
nus to a nucleotide binding Walker B motif based on
sequence similarity, and found that a D178N substitution
abolished ATP-mediated upregulation (Kwak et al.,
2000). Our structure shows that this segment is part of
outer helix 2 rather than forming the typical Walker B
b strand and is on the face opposite the ATP found in
our structure. Furthermore, one of our negative control
mutants, R181A, still binds ATP, even though the R181
sidechain is adjacent to D178 in our structure. Overall,
the ATP-binding site we observe is unlike that of most
known nucleotide triphosphate binding proteins or hydro-
lases, which have aWalker A or P loopmotif (GxxGxGKST
where x is any amino acid; Walker et al., 1982) interacting
with the nucleotide’s a and b phosphates.
Mutations in the ATP-Binding Site of TRPV1 Affect
Its Response to Capsaicin
Asmentioned above, it has been reported that intracellular
ATP modulates TRPV1 desensitization. Kwak and col-
leagues proposed that TRPV1 binds ATP directly (Kwak
et al., 2000). In contrast, Liu and colleagues argued that
intracellular ATP is required for resynthesis of PIP2 (Liu
et al., 2005). In their model, PIP2 is rapidly hydrolyzed
upon TRPV1 activation and depletion of the PIP2 pool in
the absence of ATP leads to channel inactivation (Liu
et al., 2005).
To test whether the ATP-binding site on the TRPV1-
ARD is important for channel function, the mutations that
impair ATP binding were introduced into full-length rat
TRPV1. We initially characterized the behavior of wild-
type rat TRPV1 in baculovirus-infected Sf21 insect cells.
In whole-cell patch-clamp electrophysiology experiments,
the insect-cell-expressed TRPV1 channel was sensitive to
capsaicin and capsazepine, a competitive antagonist of
capsaicin, in the same concentration range as TRPV1 ex-
pressed endogeneously in dorsal root ganglions, or heter-
ologously in HEK293 cells or Xenopus laevis oocytes (Fig-
ures S2 and S3) (Jordt and Julius, 2002; Voets et al., 2004).
Mock-infected insect cells had no endogenous capsaicin-
evoked current (Figure S2B).
Repeated capsaicin applications lead to strong tachy-
phylaxis of TRPV1 current in the absence of ATP in the
recording pipette (Figure 3). That is, current responses
are nearly eliminated upon repeated applications of cap-
saicin. Of note, TRPV1 showed faster acute desensitiza-
tion when expressed in HEK293 cells, compared to insect
cells (Figure S3). Adding 4 mM ATP to the recording pi-
pette essentially eliminated tachyphylaxis in insect cells
(Figure 3). ATPgS, a nonhydrolyzable analog, also essen-
tially eliminated tachyphylaxis, whereas an alternative
Neuron
Multiligand-Binding Site in TRPV1 Ankyrin RepeatsFigure 3. ATP and Nonhydrolyzable Analogs Sensitize TRPV1 and Reduce Tachyphylaxis
(A) Recordings from TRPV1-expressing insect cells in the absence or presence of nucleotide in the recording pipette, as indicated. For the recordings
in the presence of nucleotide, 4 mM nucleotide was added to the pipette (intracellular) solution and was therefore present throughout the recording.
Cells were repeatedly stimulated with 200 nM capsaicin for 3 min with 3 min washouts. The +80 mV (red) and 80 mV (black) currents are shown,
extracted from 1500 ms voltage ramps.
(B and C) Mean current amplitudes for successive capsaicin applications, normalized to the current amplitudes obtained on the first application (B)
and mean current density of the maximal response to the first capsaicin application normalized to the cell capacitance (C) in the absence (black) or
presence of ATP (gray), ATPgS (yellow), or AMP-PCP (white) (n = 4, 4, 5, and 5 cells, respectively). Error bars are SEM.
(D) Coomassie-stained gel of wild-type TRPV1-ARD protein bound to ATP-agarose in the absence or presence of the indicated concentration of
competing ATP or ATP analogs.nonhydrolyzable analog, AMP-PCP, had an intermediate
effect (Figure 3). This strongly correlated with the ability
of the reagents to compete TRPV1-ARD binding to ATP-
agarose (ATPgS  ATP > AMP-PCP; Figure 3D). In the
crystal structure, K160 contacts the b-g-bridging oxygen
of ATP. This oxygen is replaced by a methylene group in
AMP-PCP, likely explaining its reduced affinity. Overall,
the data support the idea that the effect of ATP on
TRPV1 tachyphylaxis is mediated through a direct interac-
tion with the TRPV1-ARD, rather than indirectly through
cellular metabolism.
TRPV1 channels with mutations in the ATP-binding
site—K155A, K160A, or Y199A/Q202A—showed little ta-
chyphylaxis even in the absence of ATP, while the two
negative control mutants—R181A and K265A—had es-
sentially wild-type behavior (Figures 4A and 4B). To de-
scribe and compare tachyphylaxis quantitatively we mea-
sured the maximal current amplitude evoked by repeated3 min applications of 200 nM capsaicin (Figure 4B). The
prolonged first capsaicin application (8 min) ensured that
we had reached maximal current in the first application,
and thereby maximized the tachyphylaxis response,
even for the K155A, K160A, or Y199A/Q202A mutants,
which exhibited slow activation kinetics for the first capsa-
icin application (Figure 4A). Interestingly, the slow activa-
tion of the mutants was ATP-independent. The Y199A/
Q202A mutant also had a slow deactivation after capsai-
cin washout (Figure 4A).
We and others have observed that the amount of TRPV1
desensitization is at least in part related to initial current
densities (e.g., Bhave et al., 2002 and Mohapatra and
Nau, 2003). Initial current densities reflect the amount of
calcium that enters the cell, activating the desensitization
process. To rule out the possibility that the lack of tachy-
phylaxis in the TRPV1 mutants is due to either poor cell
surface expression (overall expression levels of wild-typeNeuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc. 909
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Multiligand-Binding Site in TRPV1 Ankyrin RepeatsFigure 4. Mutations within the ATP-Binding Site Eliminate Tachyphylaxis in the Absence of ATP
(A) Sample inward and outward current traces from Sf21 insect cells expressing either wild-type or mutant TRPV1 and stimulated with repeated
applications of 200 nM capsaicin (gray bars). On the left are representative traces from cells recorded in the absence of ATP. For the cells recorded
in the presence of ATP (right), 4 mMATPwas added to the pipette (intracellular) solution and is therefore present throughout the recording. Cells were
first stimulated with capsaicin for 8 min followed by 8 min washout, and each subsequent capsaicin stimulation and washout was 3 min. The +80 mV
(red) and 80 mV (black) currents are shown, extracted from 1500 ms voltage ramps.
(B and C) Mean current amplitudes for successive capsaicin applications, normalized to the current amplitudes obtained on the first application, for
cells measured in the absence (top) or presence (bottom) of ATP (B); and mean current density of the maximal response to the first capsaicin appli-
cation normalized to the cell capacitance (C). The values were calculated from current amplitudes at 80mV (negative scale) and +80 mV (positive
scale) measured in experiments as shown in (A). Bars represent mean ± SEM (n = 11/5, 7/7, 9/8, 8/5, 5/7, 7/5 for WT, K155A, K160A, Y199A/Q202A,
R181A, and K265A without or with ATP, respectively).
(D) Capsaicin dose-response curves for TRPV1 and mutants in the absence of ATP. Responses to each dose of capsaicin were normalized to the
maximum response measured in each cell, and plotted against the capsaicin concentration. The lines represent the fit of the data to the Hill equation.
EC50 values and Hill coefficients (n) were as follows: 167 ± 9 nM, n = 1.9 for wild-type; 89 ± 3 nM, n = 2.5 for K155A; 49.4 ± 0.9 nM, n = 1.4 for K160A;
and 45 ± 5 nM, n = 0.9 for Y199A/Q202A. Curves were obtained from seven cells each. Error bars are SEM.910 Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc.
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Multiligand-Binding Site in TRPV1 Ankyrin RepeatsFigure 5. ATP Does Not Shift the Voltage Dependence of Wild-Type TRPV1 or the K155A Mutant
(A) Sample whole-cell current traces from wild-type TRPV1 (WT) expressed in Sf21 insect cells in response to the indicated voltage protocol after
reaching steady state to the application of 200 nM capsaicin, without (middle) or with 4 mM ATP (right) in the pipette solution.
(B) Current density (top) and normalized current (bottom) versus voltage for the aggregate data.
(C) Activation curves of wild-type (black) and K155A (red) in the presence (open circles) and absence (filled circles) of 4 mM ATP calculated from the
tail currents measured during the first milliseconds after the step to 160 mV in experiments as shown in (A) and normalized to the maximal tail cur-
rent. Lines represent the Boltzmann function fit to the data.
(D) Averagemaximum tail current amplitude fromwild-type andK155ATRPV1 activated by 200 nMcapsaicin. For (B), (C), and (D), values are average ±
SEM (n = 7).and mutant TRPV1 proteins were indistinguishable by
western blot; Figure S4) or smaller current amplitudes,
we measured the maximal current density of the first
capsaicin response in the presence or absence of ATP
(Figure 4C). All mutant channels had initial current densi-
ties similar to or greater than wild-type TRPV1 in the
absence of ATP and similar current voltage relationships
(Figure S2C), thereby ruling out an effect of the initial
current density on tachyphylaxis. Interestingly, in the pres-
ence of 4 mM ATP (and likewise for 4 mM ATPgS and
4 mM AMP-PCP; Figure 3C), wild-type TRPV1 was signif-
icantly sensitized with an inward current density about
3-fold higher than in the absence of ATP, while the
K155A, K160A, or Y199A/Q202A mutant channels show
little sensitization. Capsaicin dose-response curves ob-
tained by applying steps of increasing concentrations of
capsaicin in the absence of ATP also confirm that the
lack of tachyphylaxis shown by the TRPV1 mutants is
not due to impaired capsaicin sensitivity (Figure 4D). In
fact, the mutant channels were slightly more sensitive to
capsaicin than the wild-type channel.
Voets and colleagues showed that both temperature
and capsaicin shift the voltage dependence of TRPV1 ac-
tivation, allowing TRPV1 to open at more negative mem-
brane potentials (Voets et al., 2004). In order to determine
whether ATP also shifts the voltage dependence of activa-
tion, activation curves under steady-state capsaicin stim-
ulation were determined from tail currents at 160 mV in
a voltage step protocol for wild-type and K155A TRPV1
in the presence or absence of ATP (Figure 5). Wild-type
TRPV1 did not show any significant shift in the midpointof voltage activation (V1/2) in the presence of 4 mM ATP
(V1/2 77.5 ± 1.9 mV and 76.2 ± 3.5 mV with and without
ATP, respectively. n = 7). The V1/2 of K155A was also un-
affected by ATP (106 ± 1.9 mV and 113 ± 8.4 mV with and
without ATP, respectively. n = 7). However, the addition of
ATP significantly increased the maximal tail current ampli-
tude of wild-type TRPV1, while the K155A tail current
magnitude was unaffected (Figure 5D). Addition of ATP,
therefore, results in increased maximal conductance but
does not change the voltage dependence properties of
TRPV1. The increased conductance could be due to
a combination of several factors, including an increased
probability for the channel to be in an open state, an
increase in number of channels available for activation,
or an increase of individual channel conductance.
In summary, our electrophysiology results demonstrate
that the residues within the ATP-binding site in TRPV1-
ARD are important for TRPV1 channel regulation, since
mutations in the ATP-binding site impair tachyphylaxis
and ATP-mediated sensitization. These observations are
inconsistent with a simple model where ATP binding to
TRPV1 sensitizes the channel and reduces tachyphylaxis.
In that case, the TRPV1 mutants would show tachyphy-
laxis both in the absence and presence of ATP, contrary
to what we observed. However, our results can readily
be explained if we hypothesize an additional inhibitory
ligand which inactivates the channel. In this model, two
ligands, one sensitizing and one inhibitory, compete for
the same binding site, and themutations impairing binding
of the sensitizing ATP ligand also impair TRPV1 inhibition
by the other inhibitory ligand. By impairing interactionsNeuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc. 911
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Multiligand-Binding Site in TRPV1 Ankyrin RepeatsFigure 6. Preventing PIP2 Depletion Reduces TRPV1 Tachyphylaxis
(A) Recording from an insect cell expressing WT-TRPV1, showing that 30 mM PIP2 in the recording pipette partially reduces tachyphylaxis.
(B) Aggregate data from four successive capsaicin applications on several cells with (gray bars) or without PIP2 (black bars) in the recording pipette
(n = 5 and 8, respectively). Error bars are SEM.
(C) Recording from a TRPV1-expressing insect cell in the presence of 18 mM control compound U73343 (left) or 18 mMPLC inhibitor U73122 (right) in
the recording pipette.
(D) Aggregate data from four successive capsaicin applications in the presence of U73122 (gray bars) or U73343 (black bars), (n = 4 and 5 cells,
respectively). Error bars are SEM.
(E) TRPV1-ARDdoes not bind PIP2-containing artificial liposomes. TRPV1-ARDdid not coprecipitate with liposomes containing PIP2 (left), while under
the same conditions, the PH domain of PLCd1, fused to GST, was precipitated with liposomes containing PIP2 (right).with both the sensitizing and inhibitory ligand, the mutants
lack tachyphylaxis.
PIP2 Also Prevents TRPV1 Tachyphylaxis
Several reports suggest that TRPV1 is regulated by PIP2,
although there are discrepancies about its regulatory
role. Two groups reported that PIP2 upregulates TRPV1
and that PIP2 depletion desensitizes the channel in mam-
malian cells (Liu et al., 2005; Stein et al., 2006), while Pre-
scott and Julius have provided evidence using a Xenopus
leavis oocyte system suggesting that PIP2 is an inhibitor of
TRPV1 (Prescott and Julius, 2003). There is evidence sup-
porting an indirect role for ATP in replenishing PIP2 in912 Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc.HEK293 cells (Liu et al., 2005). We therefore decided to
test whether PIP2 levels also modulate TRPV1 function
in insect cells using electrophysiology; that is, whether
ATP may regulate TRPV1 by multiple mechanisms.
When 30 mM PIP2 was added to the intracellular pipette
solution to reduce PIP2 depletion, we observed a partial
reduction in tachyphylaxis to repeated capsaicin applica-
tions in the absence of ATP (Figures 6A and 6B). This
indicates that PIP2 sensitizes TRPV1 in insect cells and
suggests that PIP2 depletion in the absence of ATP con-
tributes to the observed tachyphylaxis. In a second set
of experiments, we investigated channel behavior in the
presence of phospholipase C (PLC) inhibitor U73122
Neuron
Multiligand-Binding Site in TRPV1 Ankyrin Repeats(Smith et al., 1990) to prevent PIP2 degradation by endog-
enous phospholipases or its inactive analog U73343. Ad-
dition of 18 mMU73122 inhibitor to the intracellular pipette
solution nearly completely eliminated tachyphylaxis in
TRPV1-expressing insect cells, whereas cells treated
with the control U73343 compound (18 mM) showed
wild-type behavior (Figures 6C and 6D). These two exper-
iments indicate that the presence of PIP2 prevents TRPV1
tachyphylaxis in insect cells, consistent with evidence ob-
tained with TRPV1 expressed in HEK293 cells (Liu et al.,
2005).
Of note, PIP2 has been shown to physically interact with
a C-terminal fragment of TRPV1 (Kwon et al., 2007). Be-
cause our electrophysiology data demonstrate that ATP
and PIP2 can both prevent TRPV1 tachyphylaxis, we
aimed to determine whether the TRPV1-ARD can also
bind to phosphoinositides in vitro. Under conditions where
the phospholipase C d1 PH domain binds to artificial lipo-
somes containing PIP2, no binding of the TRPV1-ARD is
observed (Figure 6E). However, in cells, the colocalization
of TRPV1 and PIP2 at the cell membrane results in a higher
effective concentration of PIP2, and we cannot completely
rule out that PIP2 binds the isolated TRPV1-ARD with an
affinity too weak to detect in our assays but still physiolog-
ically relevant.
Role of CaM in TRPV1 Desensitization
and Tachyphylaxis
Our experiments indicate that ATP and PIP2 sensitize
TRPV1 in agreement with previously published data (Liu
et al., 2005; Stein et al., 2006). We next aimed to identify
the inhibitory ligand that interacts with the TRPV1-ARD
to cause tachyphylaxis. A good candidate for this inhibitor
is CaM. It has been reported that Ca2+-CaM binds to pep-
tides from the N-terminal region of TRPV1 and that resi-
dues 189–222 are important determinants for binding
(Rosenbaum et al., 2004). These residues form finger 2
and inner and outer helices 3 of the TRPV1-ARD (Figure 1).
The Ca2+-CaM / TRPV1 interaction was found to reduce
channel open probability (Rosenbaum et al., 2004). It is
also known that TRPV1 desensitization is a calcium-de-
pendent process, as its observation by electrophysiology
requires calcium in the recording solution (Numazaki et al.,
2003).
In order to test the role of CaM in TRPV1 tachyphylaxis,
we aimed to prevent CaM association with TRPV1 in cells
and assay, using electrophysiology, for changes in
capsaicin-evoked responses. We used a mouse mono-
clonal anti-CaM antibody (CaM85) to sequester CaM in
TRPV1-transfected HEK293 cells. Of note, Sf21 CaM (ac-
cession number DY793505; Deng et al., 2006) and rat
CaM are 98% identical (human and rat CaM are 100%
identical) with the few differences localized at the C termi-
nus. It is therefore very likely that the rat TRPV1 protein in-
teracts with insect CaM when expressed in insect cells.
However, since most anti-CaM antibodies, including
CaM85, target the mammalian CaM C terminus, we
usedHEK293 cells rather than insect cells for these exper-iments. When added to the intracellular pipette solution,
the anti-CaMantibody reduced both acute desensitization
and tachyphylaxis of the TRPV1-mediated inward cur-
rents, whereas an isotype-matched control antibody had
no effect on the TRPV1 response (Figures 7A and 7B).
Interestingly, addition of CaM85 also resulted in slower
TRPV1 activation in the second, third, and fourth capsai-
cin applications (Figure 7A), similar to that observed for
the K155A, K160A and Y199A/Q202Amutants (Figure 4A).
Reducing the CaM levels in TRPV1-expressing HEK293
cells using RNAi produced similar results, although the
amplitude of the effect was smaller, likely because the
CaM knock down was only partial (Figure S5). Our data
therefore support the hypothesis that CaM is the inhibitory
molecule causing TRPV1 tachyphylaxis.
CaM Interacts with the TRPV1-ARD
Our electrophysiology data show that CaM is necessary
for TRPV1 tachyphylaxis. To determine the extent of the
interplay between ATP and CaM in regulating TRPV1 sen-
sitivity, we tested whether the TRPV1-ARD also binds
CaM using size exclusion chromatography. Purified CaM
and TRPV1-ARD were incubated with Ca2+, EGTA, or
Ca2+ plus ATP and analyzed by size exclusion chromatog-
raphy at salt concentrations corresponding to physiologi-
cal osmolarity (Figures 7C–7E). In the presence of 0.16
mM Ca2+, the proteins eluted at a higher apparent molec-
ular weight, indicating complex formation (Figure 7C)
(Sf21 CaM also forms the same complex [Figure S6B]).
The observed shift in peak elution volume and analysis
of eluted fractions by SDS-polyacrylamide gel electropho-
resis (Figure S6A) are both consistent with formation of
a 1:1 stoichiometric complex. This complex was Ca2+-
dependent (Figure 7D) and dissociated in the presence
of ATP (Figure 7E), suggesting that CaM and ATP bind the
same region on the TRPV1-ARD. Note that we determined
that 5 mM ATP and 2 mM Ca2+ corresponds to 3.2 mM
free ATP and 0.16mM free Ca2+ in our size exclusion chro-
matography buffer, using MaxChelator (Patton et al.,
2004). TRPV1-ARD failed to shift with CaM1234, a CaM
mutant that no longer binds Ca2+ (Keen et al., 1999), by
size exclusion chromatography (Figure S6C), further
demonstrating the Ca2+-dependence of the complex.
The homologous TRPV2-ARD, which did not precipitate
with ATP-agarose, similarly did not associate with CaM
(Figure S6D).
Furthermore, the TRPV1-ARD mutants K155A and
K160A, which no longer bind ATP, did not interact with
CaM in our size exclusion chromatography assay (Figures
7F and 7G), emphasizing that the binding surface on
TRPV1-ARD is at least partially shared by both ligands.
The TRPV1-ARD Y199A/Q202A mutant, where residues
important for interactions with the adenine moiety of ATP
were mutated, formed a complex with CaM that eluted
earlier than the complex with wild-type TRPV1-ARD (Fig-
ure 7G). Coomassie-stained gels indicated that the com-
plex still had a 1:1 stoichiometric ratio (data not shown),
suggesting that the different elution properties may beNeuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc. 913
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with TRPV1-ARD
(A) Sample whole-cell patch-clamp recordings of TRPV1-expressing HEK293 cells. The monoclonal anti-CaM antibody CaM85 (2 mg/mL) inhibits
TRPV1 tachyphylaxis when added to the intracellular pipette solution (compare traces on the left and right), whereas 2 mg/mL isotype-matched con-
trol antibody has no effect (middle). Recordings started 5 min after break-in to allow the cells to stabilize and the antibodies to diffuse through the
cells. The +80 mV (red) and –80 mV (black) currents are shown, extracted from 1500 ms voltage ramps.
(B) Normalized amplitudes of the inward currents (at80mV) recorded fromHEK293 cells in the presence or absence of antibody (n = 3, 3, and 5 cells
for wild-type, control, and CaM85 antibodies, respectively). Error bars are SEM.
(C–E) When mixed together in the presence of 0.16 mM Ca2+, CaM (25.5 nmol) and TRPV1-ARD (25.5 nmol) elute as a higher molecular weight com-
plex from a size exclusion chromatography column (C). This complex is disrupted by replacement of Ca2+ with 5 mM of the chelating agent EGTA (D),
or by addition of 5 mM ATP with 2 mMCa2+ ([E], free ATP = 3.2 mM, free Ca2+ = 0.16 mM). Elution volumes of molecular weight standards (in kDa) are
indicated in panel (C). Shown are representative traces from three experiments.
(F and G) Wild-type and mutant TRPV1-ARDs (12.5 nmol) were injected on a size exclusion chromatography column alone (F), or together with CaM
(12.5 nmol) (G), all in the presence of 2 mMCaCl2. The vertical dashed line indicates the peak elution volume of wild-type TRPV1-ARD alone for com-
parison between the graphs. Shown are representative traces from two experiments.due to an altered conformation or binding constant, or
higher order (e.g., 2:2) complex. Full-length TRPV1
Y199A/Q202A channels also had unique characteristics
in electrophysiology experiments presented above (Fig-
ure 4). Overall, the electrophysiology and biochemical
data clearly indicate that TRPV1-ARD binds CaM, that
the interface is at least partially shared with triphosphate
nucleotides, and that this interaction is crucial to inactiva-
tion of the channel following repeated stimulation.914 Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc.DISCUSSION
Following activation by pain-inducing stimuli, TRPV1 is
inactivated by a Ca2+-dependent mechanism. This desen-
sitization of the channel prevents continued perception of
the stimulus, and has led, at first glance paradoxically, to
the investigation of TRPV1 agonists as analgesics for the
treatment of chronic pain. Calmodulin has been identified
as a component of the inactivation machinery, although
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and possible interplay with other intracellular ligands.
Our studies identify a multiligand-binding site in the
TRPV1-ARD. Disruption of this site by mutagenesis,
guided by crystal structures with ATP occupying the
binding site, revealed two important features. First, these
mutations eliminated tachyphylaxis, suggesting that
a channel inhibitor, identified as Ca2+-CaM, no longer
bound. Second, unlike wild-type TRPV1, these mutants
were not sensitized in the presence of ATP, suggesting
that ATP binds and sensitizes wild-type TRPV1, but no
longer bound the mutants. Figure 8 illustrates the model
for the modulation of TRPV1 sensitivity that emerges
from our data. In resting cells, the sensitizer concentration
is high, and the intracellular calcium concentration is low.
Under these conditions, the TRPV1-ARD is bound to
a sensitizer, likely ATP, and the channel is sensitized.
Upon TRPV1 activation, Ca2+ influx activates CaM, and
Ca2+-CaM replaces the sensitizer on TRPV1 and gener-
ates an inactivated state of the channel. Although some
aspects remain hypothetical, the model incorporates our
data and much of the literature on TRPV1 regulation by
ATP, PIP2 and CaM, and provides a basis for future exper-
iments. Below we summarize the evidence in support of
this model.
Calmodulin is clearly implicated as the inhibitory ligand.
The use of CaM as a Ca2+ sensor to either facilitate or in-
hibit activity is a common feature of numerous channels,
including other TRP family members (Niemeyer, 2005;
Saimi and Kung, 2002; Zhu, 2005). Our data show that
CaM binds the TRPV1-ARD only in the presence of Ca2+
and that CaM sequestration prevents tachyphylaxis, as
do mutations that alter Ca2+-CaM/TRPV1-ARD complex
formation. Hence, when TRPV1 channels open, Ca2+ en-
ters the cell and binds CaM, and Ca2+-CaM engages the
ARD to close the channel. Previous studies have impli-
cated CaM binding to N- and C-terminal regions of
TRPV1. CaM was found to interact with TRPV1 in
a Ca2+-independent manner (Rosenbaum et al., 2004),
and binding of CaM to a C-terminal region of TRPV1 (res-
idues 767–800) was Ca2+-independent (Numazaki et al.,
2003). A Ca2+-dependent interaction was mapped to res-
idues 189–222 using isolated peptides (Rosenbaum et al.,
2004). This last observation agrees with our data using the
folded TRPV1-ARD, since we implicate residues within
and adjacent to this segment in the tertiary structure as
important for the interactionwith CaM. In aggregate, these
findings suggest that CaM may be anchored in a Ca2+-
independent manner to the C terminus such that, upon
Ca2+ entry after channel opening, Ca2+-CaM crosslinks
the N and C termini of TRPV1 and inactivates the channel.
ATP can bind the TRPV1-ARD and sensitize the chan-
nel, generating larger currents in response to capsaicin
application. Our results with nonhydrolysable ATP ana-
logs (Figure 3) strongly support that direct ATP binding
sensitizes TRPV1. Other ion channels are regulated by
ATP, tying channel function to metabolism. In particular,
KATP channels, which are widely expressed in contractiletissues, the brain and pancreatic b cells, modulate activity
based on intracellular ADP/ATP levels to dampen cell
excitability during metabolic stress or promote insulin
release, depending on the cell type (Nichols, 2006). How-
ever, ATP binding to TRPV1 is inhibited by divalent
cations, and hence its role in vivo, where most ATP is che-
lated by Mg2+, is uncertain. Still, the cellular concentration
of unchelated ATP ranges from 0.3–0.7 mM ((Taylor et al.,
1991) and references therein). Therefore, ATP binding to
the ARD suggests an elegant desensitization mechanism:
in a resting cell, ATP is bound and the channel sensitized,
but after channel opening, Ca2+ andMg2+ flow inward and
chelate and release the ATP from TRPV1-ARD. The bind-
ing site is now accessible to interact with Ca2+-CaM.
ATP has also been shown to act indirectly via phospho-
ryl transfer to replenish PIP2 (Liu et al., 2005), and we and
others have observed that PIP2 sensitizes TRPV1 (Liu
et al., 2005; Stein et al., 2006). PIP2 binds the TRPV1 C-
terminal region and, analogous to ATP binding at the
TRPV1-ARD, PIP2 competes with CaM for binding to the
TRPV1 C terminus (Kwon et al., 2007). Another report
highlights the importance of the C-terminal TRP box, at
least in TRPM8, TRPM5, and TRPV5, in mediating the
effects of PIP2 (Roha´cs et al., 2005). An appealing model
is that in resting cells, which have high PIP2, TRPV1 is
bound to PIP2, likely through its C terminus, and sensi-
tized. Following channel opening, Ca2+ enters and
activates phospholipase C, depleting the PIP2 pool.
Ca2+-CaM now binds the TRPV1-ARD (our work and
Rosenbaum et al., 2004) and TRPV1-C-terminus (Kwon
et al., 2007; Numazaki et al., 2003) and stabilizes an inac-
tivated state of the channel.
A recent paper describes a role for PIP2 in regulating the
trafficking of TRPV1 to the plasma membrane (Stein et al.,
2006). However, we did not observe changes in
Figure 8. Model of Modulatory Interactions with the TRPV1-
ARD Ligand-Binding Site
In the sensitized state, the N-terminal TRPV1-ARD is bound to ATP,
and PIP2 is bound to a C-terminal site. Intracellular calcium influx
causes release of ATP and degradation of PIP2. Ca
2+-CaM now binds
the exposed TRPV1-ARD, generating an inactive, desensitized confor-
mation of the channel.Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc. 915
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patch-clamp electrophysiology experiments. It is there-
fore unlikely that the current changes we observed are
due to a change in the number of channels localized at
the plasmamembrane, although such trafficking may pro-
vide an additional layer of TRPV1 regulation in vivo.
Ion channels are often regulated by phosphorylation.
There is growing evidence that Ca2+-dependent dephos-
phorylation of the cytosolic N terminus of TRPV1 is impli-
cated in channel desensitization (see Tominaga and Tomi-
naga, 2005 for a review). In particular, protein kinase A
(PKA) phosphorylates several residues within TRPV1
(Bhave et al., 2002; Mohapatra and Nau, 2003), including
S116, which is on inner helix 1 of the TRPV1-ARD, in close
proximity to the g-phosphate of the bound ATP in our
structure. Src-dependent phosphorylation of Y200 in hu-
man TRPV1 (Y199 in rat TRPV1) has also been observed
(Jin et al., 2004). Because S116 and Y199 are located
near the binding site in TRPV1-ARD, the negative charges
introduced by their phosphorylation could interfere with
binding of negatively charged CaM (calculated isoelectric
point of 4.1). Although this model requires further investi-
gation, it suggests that phosphorylation could provide
another regulatory layer to prevent Ca2+-induced desensi-
tization by preventing interactions with CaM.
The ATP-binding site within the TRPV1-ARD is very well
conserved between species, while significant divergence
can be found within the TRPV subfamily (Figure S7).
TRPV3 shows the highest level of sequence similarity,
and it would therefore be interesting to investigate
whether ATP and/or CaM play a role in its modulation. In
contrast, R115, which interacts with the g-phosphate of
ATP, is replaced by an aspartate (D80) in TRPV2, and
this substitution likely explains the inability of TRPV2 to as-
sociate with ATP. TRPV4, TRPV5, and TRPV6 also show
sequence divergence, and likely do not bind ATP. Dele-
tions within the TRPV6-ARD affect TRPV6 tetramerization
(Erler et al., 2004), implicating the TRPV6-ARD inmaintain-
ing the structural integrity of the TRPV6 tetramer. Further
structural and biochemical studies of the ARDs of different
TRPV proteins are needed to determine how they play dif-
ferent roles in TRPV channel function.
We have demonstrated that the TRPV1-ARDmodulates
channel activity by binding the inhibitory protein ligand
calmodulin and by binding a sensitizing small molecule li-
gand, ATP. This is, to our knowledge, the first example of
an ankyrin repeat domain binding a small molecule, ex-
panding the spectrum of functional roles for ankyrin re-
peats. A model for the Ca2+-dependent desensitization
of TRPV1 is now emerging that is consistent with multiple
studies and open to further investigation.
EXPERIMENTAL PROCEDURES
Reagents
Capsaicin and capsazepine were purchased from Sigma. All nucleo-
tides were purchased as sodium salts from Sigma except ATPgS (lith-
ium salt, Calbiochem), and stock solutions were prepared to pH 7.5916 Neuron 54, 905–918, June 21, 2007 ª2007 Elsevier Inc.with NaOH. Mouse monoclonal anti-calmodulin antibody CaM85
was from Invitrogen, and water soluble DiC8-PIP2 from Echelon
Bioscience.
Cloning of Expression Vectors
Rat TRPV1 cDNA (provided by Michael Caterina) fragments encoding
residues 101–364 (TRPV1-ARD) and 1–838 (full-length) were cloned
into the Nde I and Not I sites of pET21-C6H (Jin et al., 2006) and
pFastBac-CFlag vectors, respectively. pFastBac-CFlag was gener-
ated by ligating a short double-stranded fragment (oligos TCGACACT
AGTGACGTCGCGGCCGCTGATTACAAGGATGACGACGATAAGTGA
and GGCCTCACTTATCGTCGTCATCCTTGTAATCAGCGGCCGCGA
CGTCACTAGTG) in the Sal I and Not I sites of pFastBac1 (Invitrogen).
The N604S mutant (Rosenbaum et al., 2002), which is unglycosylated,
was used for all experiments in insect cells. Baculovirus stocks were
generated and used to infect Sf21 cells as described in the Bac-
to-Bac manual (Invitrogen). All mutants were generated by Quick-
change mutagenesis (Stratagene), and all clones were verified by
DNA sequencing. Refer to Jin et al., 2006 for TRPV2-ARD protein
expression and purification.
Expression and Purification of TRPV1-ARD
TRPV1-ARD was expressed in E. coli BL21(DE3) cultured in LB and in-
duced at OD600 = 0.5 with 75 mM IPTG at room temperature for 8–16 hr.
Selenomethionine (Se-Met)-substituted TRPV1-ARD was expressed
with feedback inhibition of methionine synthesis in fully supplemented
M9 minimal media, replacing methionine with Se-Met. Cells express-
ing TRV1-ARD were resuspended in lysis buffer (50 mM sodium phos-
phate [pH 7.0], 300 mM NaCl, 20 mM imidazole, 1 mM phenylmethyl-
sulfonylfluoride [PMSF], 10 mM b-mercaptoethanol [bME]) with 0.2
mg/ml lysozyme and lysed by sonication. The cleared lysate was
loaded onto a Ni-NTA column (Qiagen), washed with lysis buffer, and
eluted using a step gradient (60, 100, and 250 mM imidazole). Frac-
tions containing TRPV1-ARD were pooled, concentrated, dialyzed
against 20 mM sodium phosphate (pH 7.0), 20 mM NaCl, 2 mM
EDTA, 1 mM dithiothreitol (DTT), loaded on a ResourceS column (GE
Healthcare), and eluted using a linear gradient of 20–400 mM NaCl.
Pure fractions were pooled, buffer-exchanged to 20 mM Tris-HCl
(pH 7.0), 100 mM NaCl, 1 mM DTT, and concentrated to 10 mg/ml
for crystallization. The Se-Met-substituted protein was purified simi-
larly except that buffers contained 5 rather than 1 mM DTT.
Crystallization of TRPV1-ARD
Crystals were grown by hanging drop vapor diffusion with a 1:1 ratio of
protein and reservoir solution in each drop. TRPV1-ARD (crystal form I)
crystallized at 20C with 5% PEG 8000, 0.1 M sodium citrate (pH 5.0),
and 5 mM ATP in the reservoir. Crystal form II was obtained at 4C in
3%PEG 8000, 25–100mMsodium citrate (pH 4.7–5.0), and 5mMATP.
All crystals were frozen after cryoprotection in reservoir solution con-
taining 30% glycerol.
Data Collection and Structure Determination
X-ray diffraction data were collected at 100 K. Data on Se-
Met-substituted TRPV1-ARD crystal form I were collected at the APS
BM8beamline using an ADSCQ315CCDdetector. TRPV1-ARD native
data for both crystal forms were collected on a MicroMax-007 X-ray
generator equipped with an R-AXIS IV++ detector (Rigaku/MSC Inc).
All data were processed with CrystalClear (Rigaku/MSC Inc) or
HKL2000 (Otwinowski and Minor, 1997). Data collection statistics
are listed in Table 1. The 3.2 A˚ structure of TRPV1-ARD crystal form
Iwas determined using a combination of Se-MetMADphasing (SOLVE
and RESOLVE; Terwilliger, 2002) and molecular replacement with
MOLREP (Vagin and Teplyakov, 2000) using the TRPV2-ARD structure
(Jin et al., 2006). The 2.7 A˚ TRPV1-ARD crystal form II structure was
determined by molecular replacement using the crystal form I struc-
ture. Model building was done using COOT (Emsley and Cowtan,
2004) and refinement using REFMAC (Murshudov et al., 1997).
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coordinates have been deposited in the Protein Data Bank with the
entry codes 2NYJ (crystal form I) and 2PNN (crystal form II).
ATP-Agarose Pull-Downs
Each protein (12.5 mg) was diluted to 900 ml with binding buffer (10 mM
Tris [pH 7.5], 50 mMNaCl, 1 mMDTT, 0.15%w/v decyl-b-D-maltopyr-
anoside) and incubated with 75 ml ATP-agarose (50% slurry, 11 atom
spacer to ribose hydroxyls, Sigma) at 4C for 2 hr. The agarose beads
were washed three times with 1 ml binding buffer, resuspended in
sample dye and analyzed by PAGE on Coomassie-stained 12% SDS
gels.
Insect and Mammalian Cell Culture
Sf21 insect cells were grown at 27C in Hink’s TNM-FH medium con-
taining 10% (v/v) fetal bovine serum and 0.1%pluronic acid. Cells were
passaged to coverslips in the same medium without pluronic acid and
infected with the appropriate baculovirus. Currents were recorded 44–
52 hr postinfection. HEK 293 cells were transfected with rat TRPV1
subcloned into an EGFP-containing vector pTracer-CMV2 (provided
by David Clapham) using lipofectamine 2000 (Invitrogen) according
to the manufacturer’s instructions. Successfully transfected cells, as
visualized by fluorescence LED illumination, were used for current
recordings 48–72 hr posttransfection.
Electrophysiology
Currents were recorded at room temperature in the whole-cell patch-
clamp configuration using an Axopatch 200B amplifier controlled by
a Digidata 1322 and pClamp 9.2 software (Molecular Devices). Data
were sampled at 5–10 kHz. Whole-cell capacitance was recorded
from the amplifier settings. Voltage ramps (1500 ms) from 100 mV
to +100 mV were applied every 5 s from a holding potential of 0 mV.
Data were analyzed and displayed with Origin 7.0 (OriginLab Corpora-
tion) or Clampfit 9.2 (Axon Instruments). For insect cells, the standard
intracellular solution contained (in mM) 140 Na-methanesulfonate, 10
HEPES, 10 EGTA, and 2.5 NaCl; pH was adjusted to 7.2 with NaOH.
In some experiments, a Cs-containing intracellular solution was used
(in mM) 140 Cs-methanesulfonate, 10 HEPES, 10 EGTA, and 2.5
NaCl; pH was adjusted to 7.2 with CsOH. No difference was observed
between the Cs- and Na-containing solutions. The control bath (extra-
cellular) solution contained (in mM) 150 Na-gluconate, 10 HEPES, 2
CaCl2, and 10 D-glucose; pH adjusted to 7.2 with NaOH. For record-
ings from EGFP-positive HEK293 cells, the intracellular Cs-containing
solution was used, and standard extracellular solution contained (in
mM) 150 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 10 D-glucose, and 10 HEPES
at pH 7.4 adjusted with NaOH. To obtain the activation curves we used
the voltage protocol shown in Figure 5A. Tail currents were measured
during the first milliseconds after a step to 160mV and normalized to
the maximal tail current.
RNAi
Validated Stealth RNAi DuoPack duplexes targeted to human calmod-
ulin (cat. no. 1293742) and the Stealth RNAi Negative Control LO GC
Duplex (cat. no. 12935-200) were purchased from Invitrogen.
HEK293 cells were plated in 12-well plates 24 hr prior to transfection
with 40 nM Stealth RNAi duplex and 40 nM BLOCK-iT Fluorescent
Oligo (Invitrogen) using Lipofectamine 2000 (Invitrogen) at 2 mg/l. After
24 hr, high transfection efficiency was confirmed by visualizing uptake
of BLOCK-iT Fluorescent Oligo using fluorescence microscopy, and
cells were transfected with TRPV1-pTracerCMV2 as described above.
After an additional 48 hr, cells were briefly trypsinized and plated onto
12 mm coverslips, allowed to recover for 1 hr, and assayed electro-
physiologically. Calmodulin expression silencing was tested by west-
ern blot on cell lysates using anti-calmodulin antibody CaM85 (1:1000
dilution, Zymed). The blot was developed with the Super Signal West-
ern Blot Detection kit (Pierce). A loading control blot was probed with
Anti-b-Actin Antibody (1:6000 dilution, Abcam).Purification of Calmodulin
Human CaM (identical sequence to rat CaM, provided by Andrew
Bohm) and Spodoptera frugiperda CaM (provided by Philippe Four-
nier) were expressed in BL21(DE3), purified essentially as described
(Drum et al., 2001) and stored in 10 mM Tris (pH 7.5), 10 mM NaCl, 1
mM DTT. CaM1234 (provided by Joel Hirsch) was expressed in
BL21(DE3). Cells were lysed in 50 mM Tris (pH 7.5), 100 mM NaCl, 2
mM EDTA, 0.1% bME, 0.5 mM PMSF, and 0.2 mg/ml lysozyme by
freeze-thaw cycles. CaCl2 and NaCl were added to the cleared lysate
to final concentrations of 5 mM and 150 mM, respectively, and the ly-
sate was heated to 70C. The cleared lysate was loaded on a S200 16/
60 column (GE Healthcare; running buffer 10 mM Tris [pH 7.5], 10 mM
NaCl, 1 mM DTT), and CaM1234 containing fractions were further
purified on a ResourceQ column (GE Healthcare; buffer 20 mM Tris
[pH 7.5], 0.1% bME. 1mMEGTA, 0.1-1MNaCl gradient) and a second
run on a S200 16/60 column as described above.
TRPV1-ARD / CaM Complex Analysis by Size
Exclusion Chromatography
All protein samples were preincubated with an equivalent volume of
running buffer (20 mM HEPES [pH 7.4], 140 mM NaCl, 1 mM DTT,
plus CaCl2, ATP and/or EGTA as indicated) for 1 hr, followed by sepa-
ration on a S75 10/30 column (GE Healthcare) using the same running
buffer at 4C.
PIP2 Binding
To detect PIP2 binding,50 mg protein was incubated with biotinylated
liposomes (0.02 mM total lipid) with or without PtdIns(4,5)P2 (Echelon
Biosciences, Cat. No. Y-0000 and Y-P045) in 1 ml binding buffer (20
mM Tris [pH 7.5], 100 mM NaCl, 1 mM DTT, 0.3% w/v decyl-b-D-mal-
topyranoside) for 1 hr at 4C. Streptavidin-agarose (36 mg; Sigma) was
added and the samples incubated a further 1 hr, followed by three
washes with 900 ml binding buffer. The beads were resuspended in
load dye and analyzed by SDS-PAGE and Coomassie-staining.
Supplemental Data
The Supplemental Data can be found with this article online at http://
www.neuron.org/cgi/content/full/54/6/905/DC1/.
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